In accordance with the policy of the Journal, the designated author discloses a financial or other interest in the subject discussed in this article.
Same-day transradial outpatient stenting with a 6-hr course of glycoprotein IIb/IIIa receptor blockade: A feasibility study
Version of Record online: 22 APR 2002
Copyright © 2002 Wiley-Liss, Inc.
Catheterization and Cardiovascular Interventions
Volume 56, Issue 1, pages 10–13, May 2002
How to Cite
Gilchrist, I. C., Nickolaus, M. J. and Momplaisir, T. (2002), Same-day transradial outpatient stenting with a 6-hr course of glycoprotein IIb/IIIa receptor blockade: A feasibility study. Cathet. Cardiovasc. Intervent., 56: 10–13. doi: 10.1002/ccd.10093
- Issue online: 22 APR 2002
- Version of Record online: 22 APR 2002
- Manuscript Accepted: 10 OCT 2001
- Manuscript Received: 27 APR 2001
- percutaneous coronary;
The aim of the study was to explore the feasibility of same-day outpatient stent placement using a short course of intravenous antiplatelet therapy. Patients (n = 26) had stent placement and 6 hr of eptifibatide therapy. Demographics, procedural information, CPK data, and length of stay were recorded along with postdischarge outcomes. Twenty-one men and five women with median age of 60 years (49, 69) underwent transradial stenting. Baseline characteristics included diabetes 62%, hyperlipidemia 77%, prior coronary bypass surgery 19%, and unstable angina 35%. There were no CPK elevations (> 2 × normal) or ECG changes. Discharge occurred after 6.5 hr (5.8, 7.0). Neither vascular site complications nor readmission for procedure-related problems occurred. One patient later expressed concerns about discharge education. Outpatient stent placement with 6-hr infusion of GP IIb/IIIa inhibitor appears feasible and efficient in select patients. There may be challenges to meet with regard to patient education. Further studies with larger populations are needed to evaluate and optimize this approach. Cathet Cardiovasc Intervent 2002;56:10–13. © 2002 Wiley-Liss, Inc.